SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    V. Sopik, M.R. Akbari, S.A. Narod, Genetic testing for RAD51C mutations: in the clinic and community, Clinical Genetics, 2015, 88, 3
  2. 2
    Thereasa A. Rich, Ashley H. Woodson, Jennifer Litton, Banu Arun, Hereditary breast cancer syndromes and genetic testing, Journal of Surgical Oncology, 2015, 111, 1
  3. 3
    Muhammad U. Rashid, Noor Muhammad, Saima Faisal, Asim Amin, Ute Hamann, Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan, Breast Cancer Research and Treatment, 2014, 145, 3, 775

    CrossRef

  4. 4
    Ana Blanco, Sara Gutiérrez-Enríquez, Marta Santamariña, Gemma Montalban, Sandra Bonache, Judith Balmaña, Ángel Carracedo, Orland Diez, Ana Vega, RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families, Breast Cancer Research and Treatment, 2014, 147, 1, 133

    CrossRef

  5. 5
    Peter Gresner, Jolanta Gromadzinska, Ewa Twardowska, Konrad Rydzynski, Wojciech Wasowicz, Rad51C: A novel suppressor gene modulates the risk of head and neck cancer, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2014, 762, 47

    CrossRef

  6. 6
    Kara N. Maxwell, Susan M. Domchek, Familial Breast Cancer Risk, Current Breast Cancer Reports, 2013, 5, 3, 170

    CrossRef

  7. 7
    Henry T. Lynch, Trudy G. Shaw, Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations, Human Genetics, 2013, 132, 1, 1

    CrossRef

  8. 8
    Lisa Golmard, Virginie Caux-Moncoutier, Grégoire Davy, Essam Al Ageeli, Brigitte Poirot, Carole Tirapo, Dorothée Michaux, Catherine Barbaroux, Catherine d’Enghien, André Nicolas, Laurent Castéra, Xavier Sastre-Garau, Marc-Henri Stern, Claude Houdayer, Dominique Stoppa-Lyonnet, Germline mutation in the RAD51B gene confers predisposition to breast cancer, BMC Cancer, 2013, 13, 1, 484

    CrossRef

  9. 9
    F Coulet, A Fajac, C Colas, M Eyries, A Dion-Minière, R Rouzier, S Uzan, J-P Lefranc, M Carbonnel, F Cornelis, A Cortez, F Soubrier, Germline RAD51C mutations in ovarian cancer susceptibility, Clinical Genetics, 2013, 83, 4
  10. 10
    Gioia Schnurbein, Jan Hauke, Barbara Wappenschmidt, Nana Weber-Lassalle, Stefanie Engert, Heide Hellebrand, Lutz Garbes, Alexandra Becker, Guido Neidhardt, Kerstin Rhiem, Alfons Meindl, Rita K Schmutzler, Eric Hahnen, RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families, Breast Cancer Research, 2013, 15, 6, R120

    CrossRef

  11. You have free access to this content11
    FSM Hilbers, MPG Vreeswijk, CJ van Asperen, P Devilee, The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?, Clinical Genetics, 2013, 84, 5
  12. 12
    T. Hansmann, G. Pliushch, M. Leubner, P. Kroll, D. Endt, A. Gehrig, S. Preisler-Adams, P. Wieacker, T. Haaf, Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer, Human Molecular Genetics, 2012, 21, 21, 4669

    CrossRef

  13. 13
    Scott M. Weissman, Shelly M. Weiss, Anna C. Newlin, Genetic Testing by Cancer Site, The Cancer Journal, 2012, 18, 4, 320

    CrossRef

  14. 14
    Anya Kushnir, Yael Laitman, Shani Paluch Shimon, Raanan Berger, Eitan Friedman, Germline mutations in RAD51C in Jewish high cancer risk families, Breast Cancer Research and Treatment, 2012, 136, 3, 869

    CrossRef

  15. 15
    Chey Loveday, Clare Turnbull, Elise Ruark, Rosa Maria Munoz Xicola, Emma Ramsay, Deborah Hughes, Margaret Warren-Perry, Katie Snape, Diana Eccles, D Gareth Evans, Martin Gore, Anthony Renwick, Sheila Seal, Antonis C Antoniou, Nazneen Rahman, Germline RAD51C mutations confer susceptibility to ovarian cancer, Nature Genetics, 2012, 44, 5, 475

    CrossRef

  16. 16
    Alfons Meindl, Katharina Eirich, Stefanie Engert, Alexandra Becker, Daniela Endt, Nina Ditsch, Rita K Schmutzler, Detlev Schindler, Germline RAD51C mutations confer susceptibility to ovarian cancer, Nature Genetics, 2012, 44, 5, 476

    CrossRef

  17. 17
    D J Osher, K De Leeneer, G Michils, N Hamel, E Tomiak, B Poppe, K Leunen, E Legius, A Shuen, E Smith, J Arseneau, P Tonin, G Matthijs, K Claes, M D Tischkowitz, W D Foulkes, Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families, British Journal of Cancer, 2012, 106, 8, 1460

    CrossRef

  18. 18
    Liisa M Pelttari, Riikka Nurminen, Alexandra Gylfe, Lauri A Aaltonen, Johanna Schleutker, Heli Nevanlinna, Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients, BMC Cancer, 2012, 12, 1, 552

    CrossRef

  19. 19
    Paraskevi Apostolou, Athanassios Vratimos, Florentia Fostira, Breast Cancer Susceptibility Genes, eLS,